| Dr Marc Baskin, MD | |
|
10234 Rosecrans Ave, Bellflower, CA 90706-2602 | |
| (562) 920-1692 | |
| (562) 920-4643 |
| Full Name | Dr Marc Baskin |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 48 Years |
| Location | 10234 Rosecrans Ave, Bellflower, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124035076 | NPI | - | NPPES |
| 00G360970 | Medicaid | CA | |
| 00G360970 | Other | CA | BLUE SHIELD |
| 00G36970 | Medicaid | CA | |
| 030005091 | Other | CA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | G36097 (California) | Secondary |
| 207K00000X | Allergy & Immunology | 36097 (California) | Primary |
| Entity Name | Pih Health Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609233899 PECOS PAC ID: 8426951328 Enrollment ID: O20040128001177 |
News Archive
In a new study, the ability of COVID-19 vaccines to lessen transmission was examined in a large study of healthcare workers and their families, with promising results that indicate a substantially reduced rate of transmission from the vaccinated to the non-vaccinated.
Researchers at the University of Hertfordshire have developed a new structural model of a protein, which makes it possible to develop more effective drugs to target diseases such as cancer, heart disease and influenza.
BD Diagnostics, a segment of BD, today announced the European launch of the BD MAX™ Open System for molecular testing, which will enable laboratories to run both laboratory and BD- developed assays and offer enhanced testing services that elevate the standards of care at their institutions.
A survey is being launched today [Friday 14 October 2016] to help understand the psychological impact on surgeons of errors or complications which arise as a result of surgical procedures.
Researchers at UConn Health used stem cells derived from patients with Angelman syndrome to identify the underlying cellular defects that cause the rare neurogenetic disorder, an important step in the ongoing search for potential treatments for Angelman and a possible cure.
› Verified 2 days ago
| Entity Name | Pioneer Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548303589 PECOS PAC ID: 1759317696 Enrollment ID: O20050712001246 |
News Archive
In a new study, the ability of COVID-19 vaccines to lessen transmission was examined in a large study of healthcare workers and their families, with promising results that indicate a substantially reduced rate of transmission from the vaccinated to the non-vaccinated.
Researchers at the University of Hertfordshire have developed a new structural model of a protein, which makes it possible to develop more effective drugs to target diseases such as cancer, heart disease and influenza.
BD Diagnostics, a segment of BD, today announced the European launch of the BD MAX™ Open System for molecular testing, which will enable laboratories to run both laboratory and BD- developed assays and offer enhanced testing services that elevate the standards of care at their institutions.
A survey is being launched today [Friday 14 October 2016] to help understand the psychological impact on surgeons of errors or complications which arise as a result of surgical procedures.
Researchers at UConn Health used stem cells derived from patients with Angelman syndrome to identify the underlying cellular defects that cause the rare neurogenetic disorder, an important step in the ongoing search for potential treatments for Angelman and a possible cure.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marc Baskin, MD 75 Remittance Dr Dept 6008, Chicago, IL 60675-6008 Ph: (562) 282-1419 | Dr Marc Baskin, MD 10234 Rosecrans Ave, Bellflower, CA 90706-2602 Ph: (562) 920-1692 |
News Archive
In a new study, the ability of COVID-19 vaccines to lessen transmission was examined in a large study of healthcare workers and their families, with promising results that indicate a substantially reduced rate of transmission from the vaccinated to the non-vaccinated.
Researchers at the University of Hertfordshire have developed a new structural model of a protein, which makes it possible to develop more effective drugs to target diseases such as cancer, heart disease and influenza.
BD Diagnostics, a segment of BD, today announced the European launch of the BD MAX™ Open System for molecular testing, which will enable laboratories to run both laboratory and BD- developed assays and offer enhanced testing services that elevate the standards of care at their institutions.
A survey is being launched today [Friday 14 October 2016] to help understand the psychological impact on surgeons of errors or complications which arise as a result of surgical procedures.
Researchers at UConn Health used stem cells derived from patients with Angelman syndrome to identify the underlying cellular defects that cause the rare neurogenetic disorder, an important step in the ongoing search for potential treatments for Angelman and a possible cure.
› Verified 2 days ago
Sansan Wong, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 | |
Mary E. Friedman, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 | |
Margaret L. Kurohara, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 |